Rennova Health, Inc. (RNVA) financial statements (2021 and earlier)

Company profile

Business Address 400 S. AUSTRALIAN AVENUE, SUITE 800
WEST PALM BEACH, FL 33401
State of Incorp. DE
Fiscal Year End December 31
SIC 8062 - General Medical and Surgical Hospitals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 00 09
Cash and cash equivalents 00 09
Receivables 443311
Inventory, net of allowances, customer advances and progress billings 100  
Inventory 100  
Disposal group, including discontinued operation 1    
Assets held-for-sale, not part of disposal group  00  
Other undisclosed current assets 00001
Total current assets: 553321
Noncurrent Assets
Operating lease, right-of-use asset 0
Property, plant and equipment 89337
Intangible assets, net (including goodwill) 10   
Intangible assets, net (excluding goodwill) 10   
Disposal group, including discontinued operation, noncurrent assets 000  
Other undisclosed noncurrent assets 00000
Total noncurrent assets: 99337
TOTAL ASSETS: 15146628
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 302011810
Accounts payable 148434
Accrued liabilities 1511545
Taxes payable 1121 
Debt 30132112
Derivative instruments and hedges, liabilities 00   
Due to related parties 161105
Disposal group, including discontinued operation 322  
Other undisclosed current liabilities 589  
Total current liabilities: 8344252016
Noncurrent Liabilities
Long-term debt and lease obligation 0 425
Long-term debt, excluding current maturities   4 3
Capital lease obligations  22
Operating lease, liability 0
Liabilities, other than long-term debt   1207
Derivative instruments and hedges, liabilities   1207
Other undisclosed noncurrent liabilities  0 (0) 
Total noncurrent liabilities: 0016213
Total liabilities: 8444412129
Temporary equity, carrying amount   6  
Stockholders' equity
Stockholders' equity attributable to parent, including: (77)(39)(41)(15)(1)
Common stock 10000
Additional paid in capital 5093761284627
Accumulated deficit (587)(415)(169)(61)(28)
Other undisclosed stockholders' equity attributable to parent 00000
Other undisclosed stockholders' equity 89   
Total stockholders' equity: (69)(30)(41)(15)(1)
TOTAL LIABILITIES AND EQUITY: 15146628

Income statement (P&L) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 1615000
Other income  1000
Cost of revenue
(Cost of Goods and Services Sold)
 (15)(12)(1)(2)(9)
Gross profit: 13(1)(2)(9)
Operating expenses (32)(28)(21)(38)(64)
Other undisclosed operating income 15126728
Operating loss: (16)(13)(16)(32)(45)
Nonoperating income (expense) (31)0(38)(1)0
Other nonoperating income (expense) (9)0(34)(1)0
Interest and debt expense (10)(22)(9)0(3)
Loss from continuing operations before equity method investments, income taxes: (57)(34)(63)(33)(48)
Other undisclosed income from continuing operations before income taxes 10    
Loss from continuing operations before income taxes: (47)(34)(63)(33)(48)
Income tax expense (benefit)  (1)(1)19
Loss from continuing operations: (47)(35)(64)(33)(39)
Loss from discontinued operations (1) (4)  
Loss before gain (loss) on sale of properties: (48)(35)(68)(33)(39)
Other undisclosed net income (loss)    (0)3
Net loss: (48)(35)(68)(33)(36)
Other undisclosed net income (loss) attributable to parent  2113 (2)
Net loss attributable to parent: (48)(14)(55)(33)(38)
Other undisclosed net loss available to common stockholders, basic (124)(232)(53)  
Net loss available to common stockholders, diluted: (172)(246)(109)(33)(38)

Comprehensive Income ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (48)(35)(68)(33)(36)
Comprehensive loss, net of tax, attributable to parent: (48)(35)(68)(33)(36)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: